✦ LIBER ✦

P.3.c.056 Population pharmacokinetics of asenapine in patients with schizophrenia or bipolar disorder

✍ Scribed by M. Prohn; R. De Greef; S. Chapel; T. Kerbusch

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.c.059 Incidence, onset, and duration

✍ A. Szegedi; P. Cazorla; J. Zhao 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 67 KB

P-214 - Incidence, onset and duration of

✍ P. Cazorla; J. Zhao; A. Szegedi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 French ⚖ 91 KB

P.3.c.052 Higher prevalence of metabolic

✍ N.Y. Lee; H.Y. Yu; D.C. Jung; S.H. Kim; Y.S. Kim; Y.M. Ann 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 101 KB

P.3.c.014 Longitudinal changes of metabo

✍ N.Y. Lee; S.H. Kim; Y.M. Ahn; U.G. Kang; T. Youn; I.W. Chung; Y.S. Kim 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 74 KB

P.3.c.050 Effect of asenapine versus que

✍ S. Preskorn; S. Chapel; J. Panagides 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

P.3.e.010 Inhaled loxapine (AZ-004) rapi

✍ J.V. Cassella; R.S. Fishman; D. Spyker 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 61 KB